Sandor Schokker

Neoadjuvant Chemoradiotherapy Combined with Atezolizumab for Resectable Esophageal Adenocarcinoma: A Single-arm Phase II Feasibility Trial (PERFECT)

Tom van den Ende, Nicolien C. de Clercq, Mark I. van Berge Henegouwen et al. · Clinical Cancer Research · 2021 · 267 citations · Full text

Survival Differences in Pediatric Pulmonary Arterial Hypertension

Willemijn M. H. Zijlstra, Johannes M. Douwes, Erika B. Rosenzweig et al. · Journal of the American College of Cardiology · 2014 · 141 citations · Full text

Hypertension, Pulmonary Arterial Hypertension, Cardiovascular Disease +9

Circulating tumor DNA quantity is related to tumor volume and both predict survival in metastatic pancreatic ductal adenocarcinoma

Marin Strijker, Eline C. Soer, Matteo De Pastena et al. · International Journal of Cancer · 2019 · 97 citations · Full text

Phase II Feasibility and Biomarker Study of Neoadjuvant Trastuzumab and Pertuzumab With Chemoradiotherapy for Resectable Human Epidermal Growth Factor Receptor 2–Positive Esophageal Adenocarcinoma: TRAP Study

Charlotte I. Stroes, Sandor Schokker, Aafke Creemers et al. · Journal of Clinical Oncology · 2019 · 72 citations · Full text

Cerebrovascular, cardiovascular and renal hypertensive disease after hypertensive disorders of pregnancy

Sandor Schokker, Miriam F. van Oostwaard, E.M. Melman et al. · Pregnancy Hypertension · 2015 · 41 citations

Hypertension, Cardiovascular Disease, Gestational Hypertension +13